Literature DB >> 9595613

A generalized F mixture model for cure rate estimation.

Y Peng1, K B Dear, J W Denham.   

Abstract

Cure rate estimation is an important issue in clinical trials for diseases such as lymphoma and breast cancer and mixture models are the main statistical methods. In the last decade, mixture models under different distributions, such as exponential, Weibull, log-normal and Gompertz, have been discussed and used. However, these models involve stronger distributional assumptions than is desirable and inferences may not be robust to departures from these assumptions. In this paper, a mixture model is proposed using the generalized F distribution family. Although this family is seldom used because of computational difficulties, it has the advantage of being very flexible and including many commonly used distributions as special cases. The generalised F mixture model can relax the usual stronger distributional assumptions and allow the analyst to uncover structure in the data that might otherwise have been missed. This is illustrated by fitting the model to data from large-scale clinical trials with long follow-up of lymphoma patients. Computational problems with the model and model selection methods are discussed. Comparison of maximum likelihood estimates with those obtained from mixture models under other distributions are included.

Entities:  

Mesh:

Year:  1998        PMID: 9595613     DOI: 10.1002/(sici)1097-0258(19980430)17:8<813::aid-sim775>3.0.co;2-#

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  An extended cure model and model selection.

Authors:  Yingwei Peng; Jianfeng Xu
Journal:  Lifetime Data Anal       Date:  2012-01-13       Impact factor: 1.588

2.  Inference for mutually exclusive competing events through a mixture of generalized gamma distributions.

Authors:  William Checkley; Roy G Brower; Alvaro Muñoz
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

3.  A marginal regression model for multivariate failure time data with a surviving fraction.

Authors:  Yingwei Peng; Jeremy M G Taylor; Binbing Yu
Journal:  Lifetime Data Anal       Date:  2007-07-20       Impact factor: 1.588

Review 4.  Review and implementation of cure models based on first hitting times for Wiener processes.

Authors:  Jeremy Balka; Anthony F Desmond; Paul D McNicholas
Journal:  Lifetime Data Anal       Date:  2009-01-04       Impact factor: 1.588

5.  A dynamic Mover-Stayer model for recurrent event processes subject to resolution.

Authors:  Hua Shen; Richard J Cook
Journal:  Lifetime Data Anal       Date:  2013-06-20       Impact factor: 1.588

6.  Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital.

Authors:  Aylin Acar Sancar; Selen Yegenoglu; Robin de Vries; Maarten J Postma; Nimet Simsek; Petros Pechlivanoglou; Serhat Unal
Journal:  Pharm World Sci       Date:  2008-09-21

7.  Single-arm phase II trial design under parametric cure models.

Authors:  Jianrong Wu
Journal:  Pharm Stat       Date:  2015-04-01       Impact factor: 1.894

8.  Assessing the fit of parametric cure models.

Authors:  E Paul Wileyto; Yimei Li; Jinbo Chen; Daniel F Heitjan
Journal:  Biostatistics       Date:  2012-11-28       Impact factor: 5.899

9.  A Mixture Cure-Rate Model for Responses and Response Times in Time-Limit Tests.

Authors:  Yi-Hsuan Lee; Zhiliang Ying
Journal:  Psychometrika       Date:  2014-10-04       Impact factor: 2.500

10.  Methods for estimating the case fatality ratio for a novel, emerging infectious disease.

Authors:  A C Ghani; C A Donnelly; D R Cox; J T Griffin; C Fraser; T H Lam; L M Ho; W S Chan; R M Anderson; A J Hedley; G M Leung
Journal:  Am J Epidemiol       Date:  2005-08-02       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.